2009

Promoter DNA methylation of Oncostatin M receptor-β as a novel diagnostic and therapeutic marker in colon cancer
M. Kim, J. Louwagie, B. Carvalho, J. Terhaar Sive Droste, H. Park, Y. Chae, K. Yamashita, J. Liu, K. Ostrow, S. Ling, R. Guerrero-Preston, S. Demokan, Z. Yalniz, N. Dalay, G. Meijer, W. Van Criekinge and D. Sidransky
(2009) PLOS ONE, 4, e6555

Pharmacologic unmasking of epigenetically silenced genes in breast cancer
K. Ostrow, H. Park, M. Hoque, M. Kim, J. Liu, P. Argani, W. Westra, W. Van Criekinge and D. Sidransky
(2009) CLINICAL CANCER RESEARCH, 15,

GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer
D. Hellebrekers, M. Lentjes, S. van den Bosch, V. Melotte, K. Wouters, K. Daenen, K. Smits, Y. Akiyama, Y. Yuasa, S. Sanduleanu, C. Khalid-de Bakker, D. Jonkers, M. Weijenberg, J. Louwagie, W. Van Criekinge, B. Carvalho, G. Meijer, S. Baylin, J. Herman, A. de Bruine and M. van Engeland
(2009) CLINICAL CANCER RESEARCH, 15,

Spectral clustering in peptidomics studies helps to unravel modification profile of biologically active peptides and enhances peptide identification rate
G. Menschaert, T. Vandekerckhove, B. Landuyt, E. Hayakawa, L. Schoofs, W. Luyten and W. Van Criekinge
(2009) PROTEOMICS, 9,

High content analysis of human fibroblast cell cultures after exposure to space radiation
B. Dieriks, W. De Vos, G. Meesen, K. Van Oostveldt, T. De Meyer, M. Ghardi, S. Baatout and P. Van Oostveldt
(2009) RADIATION RESEARCH, 172,

Systemic telomere length and preclinical atherosclerosis : the Asklepios study
T. De Meyer, E. Rietzschel, M. De Buyzere, M. Langlois, D. De Bacquer, P. Segers, P. VAN DAMME, G. De Backer, P. Van Oostveldt, W. Van Criekinge, T. Gillebert and S. Bekaert
(2009) EUROPEAN HEART JOURNAL, 30,

E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas
T. De Meyer, I. Bijsmans, K. Van de Vijver, S. Bekaert, J. Oosting, W. Van Criekinge, M. van Engeland and N. Sieben
(2009) JOURNAL OF PATHOLOGY, 217,